The central role of nuclear factor-B in mesangial cell activaexample, by using neutralizing antibodies against platetion.
cules, it may be difficult to target only one or two proin- inflammatory response systems [4, 5] . Because there is a close relationship between NF-B and mediators of cell activation, it is possible that disruption of NF-BMesangial cell activation has been demonstrated to activating pathways may effectively influence mesangial occur in a large number of experimental models of renal cell activation. disease, as well as in various human renal diseases [1, 2]. After mesangial injury caused by any of several factors, NUCLEAR FACTOR-B including immunological and metabolic factors, a plethora of adhesion molecules, chemokines, proinflammaNuclear factor-B is a family of dimeric proteins that tory cytokines, and inflammatory enzymes appears to belong to the Rel family. They are distinguished by a cause or at least contribute to the inflammatory and homologous domain of approximately 300 amino acids, proliferative responses of the mesangial cell [1, 2] . These the Rel homology domain, that determines dimerizaproinflammatory molecules are, in part, produced by tion, nuclear localization, and binding to B element mesangial cells [1, 2] . Therapeutic approaches aimed at (5Ј-GGGPuNNPyPyCC-3Ј) in the promoter and enhancer antagonizing individual proinflammatory molecules, for regions of target genes. By far the most common type of dimer comprises a p50 subunit bound to a p65 (Rel A) subunit; however, other Rel proteins (c-Rel, Rel B, v-Rel, and p52) are also described, and various combinations are possible [4-6]. It should be noted that p50 and
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p52 are synthesized as precursor proteins of 105 and tion in cultured mesangial cells [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . We have demonstrated that LPS stimulated human mesangial cells to 100 kDa, respectively, and are generated by proteolytic processing [4] [5] [6] . The other Rel proteins are not syntheexhibit an NF-B-like activity, as assessed by electrophoretic mobility shift assays (EMSA) and supershift sized as precursors. NF-B is normally held in the cytoplasm of unstimulated cells in an inactive form bound assays with antibodies against p50 and p65 subunits of NF-B [7] . Two recent works have established that the to an inhibitory protein, IB, of which several types are recognized (IB-␣, IB-␤, and IB-␥) [4] [5] [6] . IB exposure of mouse and human mesangial cells to aggregates of immunoglobulin G and A rapidly activated a molecules contain ankryn-like repeats that interact with similar elements in Rel proteins and cover the nuclear NF-B complex constituted of p50 and p65 subunits [8, 9] . IL-1␤ and TNF-␣ have also been shown to induce localization signal [4] [5] [6] .
Following stimulation of cells by several stimuli, in-NF-B activation in rodent and human mesangial cells [8, [10] [11] [12] [13] [14] [15] [16] [17] . The generation of superoxide anion by xanthine cluding cytokines [for example, tumor necrosis factor-␣ (TNF-␣) and interleukin-1␤ (IL-1␤)], lipopolysaccharide oxidase has been shown to induce NF-B activation in mouse mesangial cells [8] . However, neither hydrogen (LPS), immunoglobulin aggregates, or reactive oxygen species (ROS), IB is phosphorylated. Phosphorylation peroxide nor diamide were capable to induce NF-B activation in mouse or human mesangial cells [8, 18] . of IB occurs at two serine residues in the amino-terminal portion of IB proteins, probably through the action Hence, proinflammatory molecules that stimulate mesangial cell activation also induce NF-B activation in of three newly described kinases (that is, NF-Binducing kinase and IB kinase ␣ and ␤) and the intracelsuch cells.
The importance of NF-B activation in mesangial cell lular production of ROS [4] [5] [6] . Phosphorylated IB is then ubiquitinated at nearby lysin residues and rapidly inflammation and proliferation has also been demonstrated indirectly by the modulation of NF-B activation degraded by proteasomes [4] [5] [6] .
The release of NF-B from IB results in the transloin mesangial cell cultures. Rovin et al have demonstrated that the inhibition of NF-B activation by the protease cation of NF-B into the nucleus, where it binds to specific sequences in the promoter regions of target genes.
inhibitor tosyl-phe-chloromethylketone, which prevents the proteolytic degradation of IB, or by an antisense Remarkably, a large number of genes appear to be targets for the activation by NF-B, among them those oligonucleotide to p65 was correlated with a dose-dependent reduction in IL-1␤-induced MCP-1 mRNA exprescoding for adhesion molecules [for example, vascularcell adhesion molecule-1 (VCAM-1) and intercellular sion in human mesangial cells [10] . Duque et al have shown that human mesangial cell pretreatment with the adhesion molecule-1 (ICAM-1)], chemokines [for example, monocyte chemoattractant protein-1 (MCP-1) and antioxidant pyrrolidine dithiocarbamate (PDTC) inhibited NF-B activation and MCP-1, IL-8, and interferon-IL-8], proinflammatory cytokines (for example, IL-1␤ and IL-6), and inflammatory enzymes [for example, ininducible protein 10 mRNA expression [9] . Kunz et al found an association between the suppression of IL-1␤-ducible nitric oxide synthase (iNOS) and phospholipase A2 (PLA2)], which are involved in the inflammatory and induced iNOS expression and the reduction of NF-B activation by cyclosporine A in rat mesangial cells [11] . proliferative responses of cells [4] [5] [6] . On the other hand, NF-B is involved in antiapoptotic genomic response,
We recently reported that lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) inhibitor, prealthough the putative antiapoptotic genes that are activated by NF-B in response to apoptotic stimuli (for vents LPS-induced NF-B activation in mesangial cells and that lovastatin inhibits mesangial cell expression and example, TNF-␣) remain to be identified [4] [5] [6] . It should be noted that the IB-␣ gene itself has a B site and is production of MCP-1 and IL-6 (abstract; Massy et al, J Am Soc Nephrol 7:1859, 1996) [7] . On the other hand, activated by NF-B, thus leading to increased synthesis of IB-␣ and termination of NF-B activation [4] [5] [6] .
a recent study has shown that FK506 activated NF-B and induced the production of IL-6 in mouse mesangial There are minor changes in the base composition of the NF-B sites and surrounding sequences, and it is cells (in contrast to the situation in T cells) [19] . Thus, various experimental maneuvers that modulate NF-B cooperation with other transcription factors, such as activator protein 1 (AP-1) and NF-IL6, may account for activation result in a parallel modulation of proinflammatory molecule production in mesangial cells (Fig. 1 ). subtle regulation of specific genes in different cell types.
In vivo evidence NUCLEAR FACTOR-B AND MESANGIAL
In animal models of renal disease, the effects of NF-B CELL ACTIVATION modulation on mesangial cell activation have not been renal cortex of mice injected with LPS [22] and rats activation. Moreover, various experimental maneuvers that inhibit NF-B activation result in a parallel reducwith immune complex nephritis [23] . Moreover, mRNA expression of IL-1␤, MCP-1, ICAM-1, and inducible tion of inflammatory response of mesangial cells. Collectively, these data suggest a pivotal role of NF-B in NOS was significantly induced by injection of antiglomerular basement membrane sera, and treatment with mesangial cell activation and designate this transcription factor as an obvious target for the modulation of this the antioxidant PDTC inhibited the increase of glomerular NF-B activity, followed by an inhibition of mRNA activation. However, these data need confirmation, particularly with respect to human renal injury. Moreover, expression of IL-1␤, MCP-1, ICAM-1, and inducible NOS in glomeruli [20] . In addition, PDTC decreased a selective and specific inhibitor(s) of NF-B in mesangial cell activation is warranted in order to avoid longurinary protein excretion and protected renal function in such rats [20] . In a similar model, treatment with term adverse consequences of suppression of such activation because NF-B also plays a critical role in the host prednisolone also prevented activation of NF-B in glomeruli and subsequent mRNA expression of proindefense. flammatory molecules [21] . Likewise, the ability of the 
